Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of XueZhiKang vs Lovastatin in Healthy Men
NCT02603770Phase 1Completed
- Sponsor
- Luye Pharma Group
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Xuezhikang in dyslipidemia (2 arms), sponsored by Luye Pharma Group. Primary endpoint: Area Under the Curve at 12 days. Started Nov 2015; status: completed.
02
Drugs
Xuezhikang
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02603770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603770.